DAX
±0,00
%
Gold
±0,00
%
BörsenNEWS.de
Home
Börse
Märkte
Trends
Aktien
Indizes
Rohstoffe
Crypto
Derivate
Analyse
Niedrigstes KGV
Beste Dividende
Marktkapitalisierung
Meistgehandelt
Beste Performance
Termine
Handelskalender
Verfallstage
Community
Foren Übersicht
Meistdiskutiert
Community
News
Aktien
Indizes
Rohstoffe
Fonds
Anleihen
Zertifikate
Optionsscheine
Devisen
Crypto
News
Schlagzeilen
Nachrichten
Community
Meldungen
DAX-News
Dow Jones-News
MDAX-News
Märkte
Aktien
Indizes
Rohstoffe
Devisen
Partner
Archiv
KI-Fragen
Suche
SMARTBROKER
+
Depot
Suche
BörsenNEWS.de
Home
Suche
Suche
Sofort finden was Sie suchen
Alles
News
Aktie
Aktie
MOTIF BIO PLC LS -,01
A14Q8Q / GB00BVVT4H71
0,00
EUR
-9,09
%
News
Chow Tai Fook Jewellery Celebrates 95-Year Anniversary and Embarks on Brand Transformation Journey
News
Projekterweiterung: 100% Projektbesitz durch genialen Deal mit Newmont! 1A-Management-Coup!
News
EQS-News: Imcyse Announces Completion of Enrollment in Phase 1 Clinical Trial of ImotopeTM IMCY-0141 for the Treatment of Multiple Sclerosis
News
EQS-News: Imcyse joins CLAIMS, a European Health Initiative Project to Make Data-Driven Precision Medicine a Reality for Patients with Multiple Sclerosis
News
EQS-News: Eckert & Ziegler: PentixaPharm Receives BfArM-Clearance for its Therapeutic to conduct a Clinical Trial in Lymphoma
News
EQS-News: Secarna Pharmaceuticals announces publication of new preclinical data showing durable antitumor activity of LNAplus™-based ASOs that both stimulate the innate immune system and suppress PD-L1 expressi
Aktie
MOTIF BIO PLC SP.ADR/20
A2DGZV / US6197841017
0,11
USD
-4,62
%
News
EQS-News: Imcyse Announces Completion of Enrollment in Phase 2 IMPACT Trial of IMCY-0098 for Type 1 Diabetes
News
Megachance für Investoren: Heute +11,25% Kursgewinn – jetzt die neue AirBnB ganz am Anfang kaufen!
News
Chow Tai Fook Jewellery Celebrates 95-Year Anniversary and Embarks on Brand Transformation Journey
News
Projekterweiterung: 100% Projektbesitz durch genialen Deal mit Newmont! 1A-Management-Coup!
News
EQS-News: Imcyse Announces Completion of Enrollment in Phase 1 Clinical Trial of ImotopeTM IMCY-0141 for the Treatment of Multiple Sclerosis
News
EQS-News: Imcyse joins CLAIMS, a European Health Initiative Project to Make Data-Driven Precision Medicine a Reality for Patients with Multiple Sclerosis
News
EQS-News: Eckert & Ziegler: PentixaPharm Receives BfArM-Clearance for its Therapeutic to conduct a Clinical Trial in Lymphoma
News
EQS-News: Secarna Pharmaceuticals announces publication of new preclinical data showing durable antitumor activity of LNAplus™-based ASOs that both stimulate the innate immune system and suppress PD-L1 expressi
News
EQS-News: Imcyse Announces Completion of Enrollment in Phase 2 IMPACT Trial of IMCY-0098 for Type 1 Diabetes
News
Megachance für Investoren: Heute +11,25% Kursgewinn – jetzt die neue AirBnB ganz am Anfang kaufen!
Aktie
MOTIF BIO PLC LS -,01
A14Q8Q / GB00BVVT4H71
0,00
EUR
-9,09
%
Aktie
MOTIF BIO PLC SP.ADR/20
A2DGZV / US6197841017
0,11
USD
-4,62
%
Anmelden
Login
Neu hier?
Jetzt Registrieren
Passwort vergessen?
weiter